NNC 0070-0002-0349

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC 0070-0002-0349, covering 2014-10-17 to 2014-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers [Phase 1]